You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR RENVELA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RENVELA

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00785629 ↗	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	DaVita Dialysis	N/A	2009-02-01	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Fresenius Medical Care North America	N/A	2009-02-01	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
NCT00785629 ↗	A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD	Completed	Genzyme, a Sanofi Company	N/A	2009-02-01	The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RENVELA

Condition Name

Chart
Table

Condition Name for RENVELA
Intervention	Trials
Hyperphosphatemia	9
Chronic Kidney Disease	6
Insulin Sensitivity	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RENVELA
Intervention	Trials
Kidney Diseases	15
Renal Insufficiency, Chronic	13
Hyperphosphatemia	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RENVELA

Trials by Country

Map
Table

Trials by Country for RENVELA
Location	Trials
United States	85
China	14
Puerto Rico	3
Denmark	2
Italy	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RENVELA
Location	Trials
New York	8
Texas	6
California	6
Colorado	5
Pennsylvania	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RENVELA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RENVELA
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	8
Phase 2	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RENVELA
Clinical Trial Phase	Trials
Completed	23
Terminated	2
Recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RENVELA

Sponsor Name

Chart
Table

Sponsor Name for RENVELA
Sponsor	Trials
Genzyme, a Sanofi Company	7
Shire	3
Ardelyx	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RENVELA
Sponsor	Trials
Industry	26
Other	20
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.